Skip to main content

Use of vasopressors for septic shock in the neonatal intensive care unit.

Journal articles  - Multicenter Study, Journal Article
Foote, HP; Benjamin, DK; Greenberg, RG; Clark, RH; Hornik, CP
Published in: J Perinatol
October 2023

OBJECTIVE: To describe outcomes for infants in the neonatal intensive care unit with septic shock based on the vasopressor administered. METHODS: This is a multicenter cohort study of infants with an episode of septic shock. We evaluated the primary outcomes of mortality and pressor-free days alive in the first week after shock using multivariable logistic and Poisson regressions. RESULTS: We identified 1592 infants. Mortality was 50%. Dopamine was the most used vasopressor (92% of episodes) and hydrocortisone was co-administered with a vasopressor in 38% of episodes. Compared to infants treated with dopamine alone, adjusted odds of mortality were significantly higher for those treated with epinephrine alone (aOR 4.7 [95% CI: 2.3-9.2]). Adjuvant hydrocortisone was associated with significantly lower adjusted odds of mortality (aOR 0.60 [0.42-0.86]) CONCLUSIONS: The use of epinephrine as either a solo agent or in combination therapy was associated with significantly worse outcomes, while adjuvant hydrocortisone was associated with decreased mortality.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Perinatol

DOI

EISSN

1476-5543

Publication Date

October 2023

Volume

43

Issue

10

Start / End Page

1274 / 1280

Location

United States

Related Subject Headings

  • Vasoconstrictor Agents
  • Shock, Septic
  • Retrospective Studies
  • Pediatrics
  • Intensive Care Units, Neonatal
  • Intensive Care Units
  • Infant, Newborn
  • Hydrocortisone
  • Humans
  • Epinephrine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Foote, H. P., Benjamin, D. K., Greenberg, R. G., Clark, R. H., & Hornik, C. P. (2023). Use of vasopressors for septic shock in the neonatal intensive care unit. J Perinatol, 43(10), 1274–1280. https://doi.org/10.1038/s41372-023-01667-8
Foote, Henry P., Daniel K. Benjamin, Rachel G. Greenberg, Reese H. Clark, and Christoph P. Hornik. “Use of vasopressors for septic shock in the neonatal intensive care unit.” J Perinatol 43, no. 10 (October 2023): 1274–80. https://doi.org/10.1038/s41372-023-01667-8.
Foote HP, Benjamin DK, Greenberg RG, Clark RH, Hornik CP. Use of vasopressors for septic shock in the neonatal intensive care unit. J Perinatol. 2023 Oct;43(10):1274–80.
Foote, Henry P., et al. “Use of vasopressors for septic shock in the neonatal intensive care unit.” J Perinatol, vol. 43, no. 10, Oct. 2023, pp. 1274–80. Pubmed, doi:10.1038/s41372-023-01667-8.
Foote HP, Benjamin DK, Greenberg RG, Clark RH, Hornik CP. Use of vasopressors for septic shock in the neonatal intensive care unit. J Perinatol. 2023 Oct;43(10):1274–1280.

Published In

J Perinatol

DOI

EISSN

1476-5543

Publication Date

October 2023

Volume

43

Issue

10

Start / End Page

1274 / 1280

Location

United States

Related Subject Headings

  • Vasoconstrictor Agents
  • Shock, Septic
  • Retrospective Studies
  • Pediatrics
  • Intensive Care Units, Neonatal
  • Intensive Care Units
  • Infant, Newborn
  • Hydrocortisone
  • Humans
  • Epinephrine